Andrea Scribante, DDS, PhD, MS
University of Pavia
11
11
10
N/A
0
2
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
+12 more interventions
Analytics
Trial Phases
No phase data
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (11)
Showing 10 of 11 trials
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Andrea Scribante, DDS, phD
University of Pavia
Shared therapeutic areas:
Worked with same sponsors:
Andrea Scribante, Associate Professor
University of Pavia
Shared therapeutic areas:
Worked with same sponsors:
Andrea Scribante, DDS, PhD.
University of Pavia
Shared therapeutic areas:
Worked with same sponsors:
Timo Sorsa, Professor
University of Helsinki
Shared therapeutic areas:
Gaetano Isola
Università degli Studi di Catania
Shared therapeutic areas:
Paula Fernstrom
Nexium Global Product Director, AstraZeneca
Shared therapeutic areas:
Ganesh Raghu, MD
University of Washington
Shared therapeutic areas:
Francisco M Tercero, MD
Research Associate, University of California San Francisco
Shared therapeutic areas:
Gaetano Isola
University of Catania
Shared therapeutic areas:
Richard Kozarek, MD
Virginia Mason Medical Center, Seattle, WA
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (11)
Showing 11 of 11 trials
Erythritol vs Ultrasonic Scaler Prophylaxis Systems on Dental Implants With Crowns Made by Different Materials
Upper Airways Cephalometric Measures Compared to Skeletal Class and Divergence
A 6-months Evaluation of Patients' Compliance and Oral Hygiene During Rapid Maxillary Expander (RME) Treatment Using "Ortodontika" Smartphone Application
Probiotics as Adjunct to Non Surgical Periodontal Therapy for Pregnant Women Oral Health
Domiciliary Management of Dental Erosion in Patients With GERD With Biomimetic Hydroxyapatite
Domiciliary Use of Hyaluronic Acid Gel Solutions vs Domiciliary Use of Chlorhexidine Mouthwash 0,20% for the Management of Peri-implant Mucositis Sites
Hyaluronic Gel vs Chlorhexidine in Periodontal Patients
In-office and Domiciliary Use of a New Ozonized Gel for the Management of Periodontal Disease
Guided Biofilm Therapy for Periodontal Patients.
Biomimetic Hydroxyapatite in Pediatric Patients With Asthma and/or Allergic Rhinitis
Ozonized In-office and Domiciliary Gels vs Chlorhexidine Gel 1% for the Management of Peri-implant Mucositis Sites
All 11 trials loaded